Amgen (AMGN) Stock Analysis: Is MariTide the Next Big Winner?
Amgen (AMGN) Deep Dive: The “MariTide” Gamble & The Horizon Debt Burden Amgen (AMGN) stands at a critical crossroads in 2025. The narrative has shifted from a safe dividend haven to a high-stakes growth play in the obesity market. At UsFinanceNow, we analyze whether the hype around MariTide (AMG 133) is justified and how the … Read more